41.34

2.18% -0.92

Revolution Medicines Inc (RVMD)

Overview News Price History Option Chain Financials Why RVMD Down? Discussions Forecast

Revolution Medicines Inc stock is traded at $41.34, with a volume of 1.11M. It is down -2.18% in the last 24 hours and up +2.94% over the past month. Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.

Previous Close:

$42.26

Open:

$42.8

24h Volume:

1.11M

Relative Volume:

0.75

Market Cap:

$7.64B

Revenue:

$29.52M

Net Income/Loss:

$-567.06M

P/E Ratio:

-11.30

EPS:

-3.66

Net Cash Flow:

$-551.11M

1W Performance:

+1.65%

1M Performance:

+2.94%

6M Performance:

-8.70%

1Y Performance:

+41.72%

1-Day Range:

$41.26

$42.94

1-Week Range:

$40.71

$42.94

52-Week Range:

$28.64

$62.40

Revolution Medicines Inc Stock (RVMD) Company Profile

Name

Revolution Medicines Inc

Sector

Healthcare (1169)

Industry

Biotechnology (678)

Phone

415-766-3638

Address

700 SAGINAW DR, REDWOOD CITY, CA

Employee

490

Twitter

Next Earnings Date

2024-11-06

Latest SEC Filings

RVMD's Discussions on Twitter

Compare RVMD with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
RVMD Revolution Medicines Inc	41.34	7.64B	29.52M	-567.06M	-551.11M	-3.66
VRTX Vertex Pharmaceuticals Inc	484.24	124.35B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	700.33	76.56B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	644.48	39.16B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	250.59	32.44B	2.25B	-278.16M	-42.59M	-2.17
BNTX Biontech Se Adr	120.01	28.77B	3.30B	-501.07M	1.03B	-2.1146

Revolution Medicines Inc Stock (RVMD) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-16-24	Reiterated	Needham	Buy
Jul-12-24	Initiated	Barclays	Overweight
Jul-08-24	Initiated	Jefferies	Buy
Apr-12-24	Reiterated	Needham	Buy
Apr-10-24	Upgrade	Raymond James	Outperform → Strong Buy
Mar-11-24	Initiated	Piper Sandler	Overweight
Jan-05-24	Upgrade	BofA Securities	Neutral → Buy
Jan-04-24	Initiated	Wedbush	Outperform
Nov-16-23	Initiated	Raymond James	Outperform
Feb-28-23	Upgrade	JP Morgan	Neutral → Overweight
Dec-14-22	Initiated	Needham	Buy
Oct-21-22	Initiated	Oppenheimer	Outperform
May-20-22	Initiated	BofA Securities	Neutral
Mar-01-22	Upgrade	Stifel	Hold → Buy
Sep-23-21	Initiated	Stifel	Hold
Aug-12-21	Downgrade	Goldman	Buy → Neutral
May-18-21	Initiated	Goldman	Buy
May-21-20	Initiated	H.C. Wainwright	Buy
Mar-09-20	Initiated	Cowen	Outperform
Mar-09-20	Initiated	Guggenheim	Buy
Mar-09-20	Initiated	JP Morgan	Neutral

View All

Revolution Medicines Inc Stock (RVMD) Latest News

Feb 19, 2025

Revolution Medicines to Announce Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025 - Nasdaq

Feb 19, 2025

Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2024 After Market Close on February 26, 2025 - The Manila Times

Feb 19, 2025

Revolution Medicines to Report Financial Results for Fourth - GlobeNewswire

Feb 19, 2025

Revolution Medicines Q4 Earnings Coming: Will Their Cancer Drug Pipeline Show Progress? - StockTitan

Feb 19, 2025

(RVMD) Proactive Strategies - Stock Traders Daily

Feb 19, 2025

Feb 17, 2025

Revolution Medicines' SWOT analysis: stock poised for growth amid clinical trials - MSN

Feb 17, 2025

Feb 15, 2025

Wilmington Savings Fund Society FSB Sells 15,167 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD) - MarketBeat

Feb 15, 2025

SG Americas Securities LLC Sells 28,515 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD) - MarketBeat

Feb 15, 2025

Empowered Funds LLC Purchases New Position in Revolution Medicines, Inc. (NASDAQ:RVMD) - MarketBeat

Feb 15, 2025

Feb 14, 2025

Mirae Asset Global Investments Co. Ltd. Sells 435 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD) - Defense World

Feb 14, 2025

Wingate Wealth Advisors Inc. Buys New Stake in Revolution Medicines, Inc. (NASDAQ:RVMD) - MarketBeat

Feb 14, 2025

Feb 13, 2025

WCM Investment Management LLC Takes $6.80 Million Position in Revolution Medicines, Inc. (NASDAQ:RVMD) - MarketBeat

Feb 13, 2025

Feb 10, 2025

Does Revolution Medicines (RVMD) Have the Potential to Rally 74.05% as Wall Street Analysts Expect? - MSN

Feb 10, 2025

Feb 08, 2025

(RVMD) Trading Advice - Stock Traders Daily

Feb 08, 2025

Why Revolution Medicines, Inc. (RVMD) Is Among the Best Healthcare Stocks To Buy According to Analysts - Yahoo Finance

Feb 08, 2025

Feb 07, 2025

12 Best Healthcare Stocks to Buy According to Analysts - Insider Monkey

Feb 07, 2025